Reference
[Please submit your publication]
|
Ohhara Y, Nakamura A, Kato Y, Yamakawa-Kobayashi K.<br> Chaperonin TRiC/CCT supports mitotic exit and entry into endocycle in Drosophila.<br> PLoS Genet (2019) 15(4) e1008121
[
PubMed ID = 31034473
]
[
RRC reference
]
Fernández-Espartero CH, Rizzo A, Fulford AD, Falo-Sanjuan J, Goutte-Gattat D, Ribeiro PS.<br> Prp8 regulates oncogene-induced hyperplastic growth in <i>Drosophila</i>.<br> Development (2018) 145(22)
[
PubMed ID = 30333215
]
[
RRC reference
]
Kovács L, Nagy O, Pál M, Udvardy A, Popescu O, Deák P.<br> Role of the deubiquitylating enzyme DmUsp5 in coupling ubiquitin equilibrium to development and apoptosis in Drosophila melanogaster.<br> PLoS One (2015) 10(3) e0120875
[
PubMed ID = 25806519
]
[
RRC reference
]
Zhang J, Liu M, Su Y, Du J, Zhu AJ.<br> A targeted in vivo RNAi screen reveals deubiquitinases as new regulators of Notch signaling.<br> G3 (Bethesda) (2012) 2(12) 1563-75
[
PubMed ID = 23275879
]
[
RRC reference
]
|
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
482 |
0 |
0 |
8 |
NM_139516.1 |
CG12082-RA (CG12082), mRNA |
0 |
0 |
4 |
4 |
2 |
NM_135667.3 |
CG6614-RA (CG6614), mRNA |
0 |
0 |
4 |
3 |
3 |
NM_057414.3 |
CG1389-RA (tor), mRNA |
0 |
0 |
3 |
5 |
3 |
NM_132740.1 |
CG15890-RA (CG15890), mRNA |
0 |
0 |
2 |
3 |
3 |
NM_206483.1 |
CG15890-RA (CG15890), mRNA, sub-group O CG3143-RB, transcript variant B (foxo), mRNA |
0 |
0 |
2 |
3 |
3 |
NM_206482.1 |
CG15890-RA (CG15890), mRNA, sub-group O CG3143-RB, transcript variant B (foxo), mRNA, sub-group O CG3143-RC, transcript variant C (foxo), mRNA |
0 |
0 |
2 |
3 |
3 |
NM_142073.3 |
CG15890-RA (CG15890), mRNA, sub-group O CG3143-RB, transcript variant B (foxo), mRNA, sub-group O CG3143-RC, transcript variant C (foxo), mRNA, sub-group O CG3143-RA, transcript variant A (foxo), mRNA |
0 |
0 |
2 |
3 |
2 |
NM_136876.2 |
CG8321-RA (CG8321), mRNA |
0 |
0 |
2 |
1 |
1 |
NM_205985.1 |
CG32975-RC, transcript variant C (nAcRalpha-34E), mRNA |
0 |
0 |
2 |
1 |
1 |
NM_205986.1 |
CG32975-RB, transcript variant B (nAcRalpha-34E), mRNA |
0 |
0 |
2 |
1 |
1 |
NM_176035.2 |
CG32975-RA, transcript variant A (nAcRalpha-34E), mRNA |
0 |
0 |
1 |
4 |
6 |
NM_169264.1 |
CG9735-RA, transcript variant A (Aats-trp), mRNA |
0 |
0 |
1 |
4 |
5 |
NM_057303.4 |
CG7831-RA (ncd), mRNA |
0 |
0 |
1 |
3 |
6 |
NM_079659.2 |
CG3937-RA, transcript variant A (cher), mRNA |
0 |
0 |
1 |
3 |
6 |
NM_206502.1 |
CG3937-RD, transcript variant D (cher), mRNA |
0 |
0 |
1 |
3 |
2 |
NM_132090.2 |
CG3446-RA (CG3446), mRNA |
0 |
0 |
1 |
2 |
7 |
NM_206558.1 |
CG33340-RA (CG33340), mRNA |
0 |
0 |
1 |
2 |
6 |
NM_140571.3 |
CG5895-RA (CG5895), mRNA |
0 |
0 |
1 |
2 |
3 |
NM_057977.3 |
CG9239-RA, transcript variant A (B4), mRNA |
0 |
0 |
1 |
2 |
3 |
NM_165046.1 |
CG9239-RB, transcript variant B (B4), mRNA |
0 |
0 |
1 |
2 |
3 |
NM_132328.1 |
CG17446-RA (CG17446), mRNA |
0 |
0 |
1 |
2 |
3 |
NM_132441.1 |
CG2174-RA, transcript variant A (Myo10A), mRNA |
0 |
0 |
1 |
2 |
3 |
NM_001042804.1 |
CG2174-RB, transcript variant B (Myo10A), mRNA |
0 |
0 |
1 |
2 |
2 |
NM_206381.1 |
CG16838-RC, transcript variant C (CG16838), mRNA |
0 |
0 |
1 |
2 |
2 |
NM_206380.1 |
CG16838-RD, transcript variant D (CG16838), mRNA |
0 |
0 |
1 |
2 |
2 |
NM_136672.2 |
CG1688-RA (CG1688), mRNA |
0 |
0 |
0 |
6 |
3 |
NM_141308.1 |
CG12170-RA (CG12170), mRNA |
0 |
0 |
0 |
6 |
3 |
NM_132199.2 |
CG2206-RA, transcript variant A (l(1)G0193), mRNA |
0 |
0 |
0 |
5 |
11 |
NM_079205.3 |
CG7507-RA, transcript variant A (Dhc64C), mRNA |
0 |
0 |
0 |
5 |
6 |
NM_170004.1 |
CG7070-RB, transcript variant B (PyK), mRNA |
|